Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
Public ClinicalTrials.gov record NCT06948838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Effectiveness of Interventions to Improve Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP. Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.
Study identification
- NCT ID
- NCT06948838
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 16,895 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 7, 2025
- Primary completion
- Aug 31, 2029
- Completion
- Aug 31, 2029
- Last update posted
- Oct 13, 2025
2025 – 2029
United States locations
- U.S. sites
- 7
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boston Healthcare for the Homeless (BHCHP) | Boston | Massachusetts | 02118 | Recruiting |
| Boston Medical Center Family Medicine | Boston | Massachusetts | 02118 | Recruiting |
| Boston Medical Center, General Internal Medicine primary care | Boston | Massachusetts | 02118 | Recruiting |
| Neighborhood Health | Boston | Massachusetts | 02118 | Recruiting |
| Mattapan Community Health Center | Boston | Massachusetts | 02126 | Recruiting |
| Manet Community Health Center | Quincy | Massachusetts | 02169 | Recruiting |
| Greater Roslindale Medical and Dental Center (GRMDC) | Roslindale | Massachusetts | 02131 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06948838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2025 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06948838 live on ClinicalTrials.gov.